Janellen Smith

Picture of Janellen Smith
Health Sciences Clinical Professor, Dermatology
School of Medicine
Director of OncoDermatology, Dermatology
School of Medicine
Co-Director, Pigmented Lesion Program, Dermatology
School of Medicine
Director, Grand Rounds and Dowling Club Lecture Series, Dermatology
School of Medicine
M.D., University of Iowa, 1982
B.S., University of Iowa, 1978, Pre-Medicine & Mathematics
Phone: (949) 824-5515
University of California, Irvine
118 Medical Surge I
Mail Code: 2400
Irvine, CA 92697
Research Interests
OncoDermatology
Awards and Honors
2024 - Teacher of the Year Award, UC Irvine Department of Dermatology
2022 - Top Dermatologists in the US, Newsweek Magazine
2021 - Mentor of the Year Nomination, UC Irvine School of Medicine
2021 - Physicians of Excellence, Orange County Medical Association
2019 - Teacher of the Year Award, UC Irvine Department of Dermatology
2019 – Present - Exceptional Women in Medicine
2015 - Present - Top Doctors, Southern California
2014 – Present - Top Doctors, Orange County, Castle Connolly
2014 - Thomas Cesario Clinician of the Year Nominee, University of California, Irvine
2011 - Hack ‘n Smack Memorial Golf Tournament to Benefit Melanoma Honoree
2006 – Present - Best Doctors in American Award
Publications
JOURNAL PUBLICATIONS
1. Collier IE, Smith J, Kronberger A, Bauer EA, Wilhelm SM, Eisen AZ, Goldberg GI. The Structure of the Human Skin Fibroblast Collagenase Gene. J Biol Chem 263(22):10711, 1988.
2. Boonyaratanakornkit, JB, Yue, L, Strachan, LR, Scalapino, KJ, LeBoit, PE, Lu Y, Leong, SP, Smith, JE, Ghadially, R, Selection of tumorigenic cells using ALDH. J Invest Dermatol. 2010 Dec;130(12):2799-808
3. Chapman LW, Elkins KR, Smith J. Eruptive Reddish-Yellow Coalescing Papules in the Axillae of a Middle-Aged Man. JAMA Dermatology. June 2016; 152(6): 715-716. PMID: 27028357.
4. Zikry J, Chapman LW, Korta DZ, Smith J. Genital Melanoma: Are We Adequately Screening our Patients? Dermatology Online Journal. 15;23 (3) Mar 2017
5. Zikry J, Chapman LW, Korta DZ, Smith J. Scrotal Melanoma: A Systematic Review of Presentation, Treatment, and Outcomes. Dermatologic Surgery: June 2017 - Volume 43 - Issue 6 - p 765–770
6. Doong JC, Chapman LW, Smith J. Linear Streaks of Atrophy and Hypopigmentation Behind the Ear: Photo Challenge. 102(1);E19-E20 Cutis July 2018
7. Elsensohn A, Thomas LW, Shiu J, Smith J. Lower extremity hyperpigmentation in MYH9 disorder. Cutis. Accepted for publication 2018
8. Chiang, BA,1 Jessica Shiu, MD, PhD,1 Ashley N Elsensohn, MD, MPH, 1 Lance W Chapman, MD, MBA,1 Sebastien de Feraudy, MD, PhD, 1 Janellen Smith, MD Classic Autoimmune Type 1 Diabetes Mellitus Following a Case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) JAAD Case Reports 4(4) 295-97 May 2018
9. Parra C, Elsensohn A, Chapman L, Smith J. An inframammary macerated erosion. Cutis. 2018 September;102(3):E10-E11
10. Shen, E, Xie, K, Jwo K, Smith J, and Mosaed S Dupilumab-induced Follicular Conjunctivitis Ocular Immunology and Inflammation, Ocul Immunol Inflamm. 2018 Oct 18:1-3
11. Lentsch, G, Balu, M, Koenig, K Tromberg, B, Zachary, C, Smith, J In vivo multiphoton microscopy of scabies. JAAD Case Rep. 2018 Nov; 4(10): 985–987
12. Hosking,A, Makdisi, J, Ortenzio, F, DeFeraudy, S, Smith, J, Linden, K. Pediatric Diffuse Cutaneous Bullous Mastocytosis: A Rare Case Report and Review of the Literature. Pediatr Dermatol. 2018 Nov;35(6):e348-e35
13. Fackler N, Zachary C, Kim DJ, Smith J, Grande-Sarpa, H Not lost to follow-up: A rare case of CHILD syndrome in a boy reappears JAAD Case Rep. 9;4(10):1010-1013 2018 Nov
14. Nguyen J, Chapman L, Smith, J Corkscrew Hair: A Trichoscopic Marker of Tinea Capitis Dermatology Online Journal, Dermatology Online Journal 24(11):14 Nov 2018
15. Lee K, Kraus C, Smith J What lengths for a Lash Int J Dermatol. 2018 Dec;57(12):1538-1539
16. Hosking A, Pouldar D, Elsensohn A, Kassira S, Smith J, deFeraudy S, A Green Brown Patch on the Dorsal Hand, JAAD Case Reports, JAAD Case Rep. 2018 Dec 6;5(1):60-62
17. Yale K, Elsensohn A, Shiu J, Amber K, Smith J. Erythematous papular rash with sparing of folds. JAAD Case Rep. 25;5(2):135-137 Jan 2019
18. Hosking A, Chapman L, Smith J, Crohn's Disease Presenting as Isolated Lower Lip Swelling, SKIN, The Journal of Cutaneous Medicine, 3(3) 226-228 May 2019
19. Shwe S, Sharma A, Elsensohn A, Doan L, Smith, J Multicentric reticulohistiocytosis in a patient with thymic carcinoma, JAAD Case Rep. 2019 Aug 5;5(8):720-722
20. Kraus C, Smith J Herpes zoster of the external ear, Int J Dermatol 2019 Sep;58(9):1083-1084
21. Hoskings A, Kraus C, Elsensohn A, Shiu J, De Feraudy S, Smith, J Ulcerated Nodules in a Sporotrichoid Distribution 9;5(10):925-927 Oct 2019
22. Kraus C, Smith J The many faces of penile lichen planus, 2019 Nov, Int J Dermatol. Int J Dermatol, 58 1460-1461
23. Zachary C, Kraus C, Smith J Painful violaceous nodules of the popliteal fossa, Sexually Transmitted Diseases, 46 (12) 820 Dec 2019
24. Juhasz M, Lacquer V, Smith, J “Peeling paint” dermatosis in a leukemia patient JAAD Case Rep 11;6(7):587-589 Mar 2020
25. Heydayati B, Kraus C, Kassira S, Smith, J Arcuate pink plaques in a female with Down’s Syndrome, Int J Dermatol 2020 Apr;59(4):e127-e128
26. Foulad D, Skupsky H, Korb M, Smith J Crusted Scabies Triggering Autonomic Dysreflexia in a Patient with Spinal Cord Injury JAAD Case Reports 19;6(7):640-642 May 2020
27. Kraus C, Smith J, Slate grey blue nails J Cutaneous Med Surg Online June 2020
28. Foulad D, Zachary C, Smith J The Fjord Sign in Crusted Scabies J Cutaneous Med Surg Online June 2020
29. Cox S, Smith J Deceptively Innocent Façade of Sebaceous Carcinoma in Muir Torre Syndrome: A Report of Two Cases in Mother and Son, Dermatologic Surgery 1;47(6):828-829 June 2020
30. Cox S, Smith J Muir Torre Syndrome and In Vitro Fertilization: One Family’s Experience JAAD Case Reports 11;6(7):587-589 July 2020
31. Pham C, Cox S, Smith J Brachioradial Pruritus in a Patient with Metastatic Breast Cancer to her Cervical Spine JAAD Case Reports, 5;6(7):619-621 July 2020
32. Suh S, Pham C, Smith J, Mesinkovska, N The Banned Sunscreen Ingredients and Their Impact on Human Health: A Systematic Review Int J Dermatology 59(9):1033-1042 Sept 2020
33. Shwe S, Sharma A, Lee B, Smith J Relapse of Plasmablastic Lymphoma with Cutaneous Involvement in an Immunocompetent Male, Ear Nose Throat J Sept 2020
34. Lentsch, G; Valdebran, M; Saknite, I; Smith, J; Linden, K; Koenig, K; Barr, R; Harris, R; Tromberg, B; Ganesan, A; Zachary, Cr; Kelly, K; Balu, M Non-invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi Pigment Cell & Melanoma Research Non-invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi Pigment Cell Melanoma Res 33(6):869-877 Nov 2020
35. Zachary C, Belzer AG, Fackler N, Shiu J, Smith J, Ghadially R, Facial Psoriasis in a Mask-like Distribution: A Case Report J Amer Academy Derm Case Reports 24;7:128-130 Nov 2020
36. Duffens A, Kraus C, Elsensohn A, Shiu J, Smith J, Ichthyosiform red-brown plaques on bilateral shins JAAD Case Rep 12;6(9):838-840 July 2020
37. Kraus C, Elsensohn A, Smith, J Chronic Red Vulvar and Perianal Erosions, International J of Women’s Dermatology 6(5) 436-7 Dec 2020
38. Kraus C, Smith J, Tense Bullae on the Hands, J of Pediatrics 223:217-18 Aug 2020
39. Urso B, Laquer V, Hillman J, Zachary C, Smith J Multifaceted Facial Tumor Posing a Therapeutic Challenge Skin The Cutaneous Medicine Journal 5(3) 316-318 May 2021
40. Dobry A, Virgen A, Mar N, Smith J Cutaneous reactions with enfortumab vedotin: a case series and review of the literature JAAD Case Rep 4;14:7-9 June 2021
41. Juhasz, M, Rojek N, Diamond C, Mandel D, Smith J Disseminated Mycobacterium abscessus infection as a cause of autosensitization JAAD Case Reports 16:47-49 Aug 2021
42. Hosking A, Chapman L, Zachary C, Smith J, Lee P Anogenital Examination Practices Among U.S. Dermatology Residents—Are We Adequately Screening Our Patients? Journal Am Acad Dermatol 85(3):762-765 Sept 2021
43. Kim DJ, Truong S, Paik A, Kraus C, Harris, RM, Barr RJ, Linden K*, Smith, J* (*senior authors) “A case of acanthosis nigricans-like mycosis fungoides.” JAAD Case Reports September 2021
44. Sattler S, Kraus CN, Lee B, Smith J. “Hyperpigmented plaques and nodules in a young man.” JAAD Case Rep. 2021 Dec 17:16:106-108. PMID: 34988275.
45. Hutchison D, Juhasz M, Smith J, Lee B. “The ‘Flolan Rash’: An Impressively Asymptomatic and Non-Inflammatory Eruption Following Long-Term Epoprostenol Therapy.” J Drugs Dermatol. 2022 Nov 1;21(11):1249-1251. PMID: 36342724.
46. Elsensohn AN, Thomas LW, Shiu J, Smith J. “Lower Leg Hyperpigmentation in MYH9-Related Disorder.” Cutis. 2022 Jan;109(1):E39-E40. PMID: 35180070.
47. Casale F, Nguyen C, Dobry A, Smith J, Mesinkovska NA. “Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis.” Australas J Dermatol. 2022 Aug;63(3):394-397. PMID: 35460570.
48. Birmingham SW, Doan LT, Smith J. “Grouped Cerebriform Papules in a Child.” J Pediatr. 2022 Sep:248:129-130. PMID: 35709955.
49. Belzer A, Nguyen MO, Talsania A, Haldas J, Smith J, Leventhal JS. “Spectrum of Dermatologic Adverse Events Associated with Amivantamab Use.” JAMA Dermatol. 2023 Jan 1;159(1):109-111. PMID: 36416832.
50. Shin L, Smith J, Shiu J, Kraus CN, Elsensohn AN. “Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review.” Int J Womens Dermatol. 2023 Jan 19;9(1):e070. PMID: 36700160.
51. Nagalla RR, Lee BA, Smith J, Kraus CN. “Eroded pigmented anogenital plaque in an elderly woman.” JAAD Case Rep. 2023 Feb 19;34:52-54. PMID: 36969315.
52. Kincaid CM, Sharma AN, Lee BA, Pinter-Brown LC, Smith J, Linden K, Mesinkovska NA. “Alopecia areata-like presentations with mogamulizumab therapy.” JAAD Case Rep. 2023 Sep 16;41:71-74. PMID: 37877094.
53. Arnold JD, Smith J. “Foscarnet-Induced Penile Ulceration.” JAMA Dermatol. 2023 Oct 1;159(10):1129. PMID: 37647057.
54. Lopez M, Hagopian G, Doan L, Lee BJ, Rojek NW, Smith J, Ignatius Ou SH, Demirdag YY, Nagasaka M. “Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab.” Allergy Asthma Clin Immunol. 2023 Oct 28;19(1):93. PMID: 37898814.
55. Bang AS, Said JT, Hirner J, Rana J, Pugliese S, Wang JY, Zaba L, Zhao L, Doan L, Smith J, Kwong BY. “Erythema dyschromicum perstans like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.” Support Care Cancer. 2024 May 15;32(6):354. PMID: 38750379.
56. Chernyak M, Hutchison D, Smith J. “Papillary thyroid cancer and cutaneous melanoma: An often under-recognized pair.” JAAD Case Rep. 2024 May 28:50:22-24. PMID: 39036614.
57. Freites-Martinez A, Apalla Z, Fattore D, Fida M, Bang AS, Smith J, Babakoohi S, Lacouture M, Sibaud V. “Supportive oncodermatology practices in Europe and the USA.” J Eur Acad Dermatol Venereol. 2024 May;38(5):e440-e443. PMID: 38058268.
58. Driscoll W, Yale K, Smith J. “A case of pembrolizumab-induced toxic epidermal necrolysis with a delayed developmental timeline.” JAAD Case Rep. 2024 Aug 30:53:27-29. PMID: 39435162.
59. Grant C, Arter Z, Smith J, Nourbakhsh SNM, Lee B, Creadore A, Mar N. “Pembrolizumab and radiation therapy for multifocal myxofibrosarcoma of the scalp: a case report.” Therapeutic Adv in Med Oncol .2;16 2024 Aug
60. Apalla Z, Freites-Martinez A, Grafanaki K, Ortiz-Brugues A, Nikolaou V, Fattore D, Sollena P, Deverapalli S, Babakoohi S, Galimont A, Kluger N, Beylot-Barry M, Larocca C, Iriarte C, Smith J, Tattersall I, Dodiukad R, Sauder M, Carrera C, Kwong B, Whitley M, Leboeuf N, Romano P, Starace M, Mateeva V, Riganti J, Hirnir J, Patel AB, Reyes-Habito CM, Kraehenbuehl L, Kheterpal M, Fide M, Hassle J, Lacouture M, Sibaud V. “Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.” J Eur Acad Dermatol Venereol. 2024 Oct 26. PMID: 39460590.
61. Halle BR, Golbari NM, Smith J, Zachary C. “Picosecond 532 nm Laser: An Optimal Device for the Reduction of Acquired Agminated Nevi.” Lasers Surg Med. 2025 Jan;57(1):37-40. PMID: 39344138.
62. Brazel D, Smith J, Ignatius Ou SH, Nagasaka M. “The User’s Guide to Amivantamab.” Target Oncol. 2025 Feb 4. PMID: 39903428.
63. Driscoll W, Zachary C, Patel A, Golbari N, Smith J. “CD30+ Lymphoproliferative Disorder Following Immune Checkpoint Inhibition in a Patient with Merkel Cell Carcinoma JAAD Case Reports (62)50-52 Aug 2025
64. Gordon E, Shah K, Chand S, Lee B, Smith J, MD2, Min M. “Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review,” JEADV Clinical Practice5 (2025): 205-210.
65. Patel A, Driscoll W, Lee CH, Zachary C, Golbari NM, Smith J. “Evaluating Artificial Intelligence Models in Dermatology: A Comparative Analysis.” JMIR Preprints. 16/03/2025:74040. DOI: 10.2196/preprints.74040.
66. Patel A, Pham C, Smith J. “Scaling the Side Effects: A Case of Apalutamide-Induced Ichthyosis.” JAAD Case Reports June 2025
67. Hosking A, Saeed L, Smith J. “Pruritic Eruption on the Extremities - Report of Two Generations Treated with Dupilumab.” JAAD Case Challenge 2025 Sep 24:65:211-214
68. Sonuga O, Patel AB, Halle Brady B, Doan, L, Smith J. “A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Young Male with Atypical Cutaneous Findings.” JAAD Case Reports 2025 Oct 17:67:8-10
69. Cho BC, Li W, Spira AI, Sauder M, Feldman J, Bozorgmehr F, Mak M, Smith J, Voon PJ, Liu B, Tian P, Tan JL, Yang CT, Shih JY, Karadurmus N, Cundom JE, Bertollo G, Cicin I, Nieva J, Ortega-Granados AL, Tomasini P, Nguyen D, Felip E, Schuchard J, Murphy SP, Anderson BG, Romero T, Xia Y, Sheng S, Bauml JM, Mahadevia PJ, Kam J, Nematian-Samani M, Simoes J, Wildgust M, Girard N. “Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.” J Thorac Oncol. 2025 Oct;20(10):1517-1530. doi: 10.1016/j.jtho.2025.07.117. Epub 2025 Sep 9. PMID: 40923969.
70. Patel AB, Driscoll W, Sharma AN, Horton L, Smith J. “Survival Outcomes in Cutaneous Angiosarcoma: A Meta Analysis.” Dermatol Surg. 2025 Sep 17. doi: 10.1097/DSS.0000000000004867. Online ahead of print. PMID: 40961959.
71. Arora JS, Mahadevan A, Smith J, Min M. “Risk of Developing Hematologic Malignancy in Patients with Autoimmune and Inflammatory Skin Diseases.” J Am Acad Dermatol. 2025 Sep 25:S0190-9622(25)02898-1. doi: 10.1016/j.jaad.2025.09.075. Online ahead of print. PMID: 41015342.
72. Patel A, Fan X, Smith J. “Management of Nail Toxicities from Fibroblast Growth Factor Receptor Inhibitors.” Journal of Drugs in Dermatology. 2026 Mar 1;25(3):263-267. doi: 10.36849/JDD.9496. PMID: 41779762.
73. Kasheri E, Smith J, Min MS. “Glucagon-like peptide-1 receptor agonists may decrease biologic initiation in hidradenitis suppurative: A TriNetX retrospective analysis.” J Am Acad Dermatol. 2025 Dec 30:S0190-9622(25)03493-0. doi: 10.1016/j.jaad.2025.12.092. PMID: 41478501.
74. Phong CH, Kasheri E, Lee BA, Smith J. “Diffuse red-brown papules in a toddler. JAAD Case Rep. 2026 Feb 17;70:146-148. doi: 10.1016/j.jdcr.2026.02.020. eCollection 2026 Apr. PMID: 41852668.
75. Patel A, Smith J, Lee A, Olson KM. “Educational Case: Mycosis fungoides Academic Pathology.” (Minor Revisions Academic Pathology).
76. Patel A, Arnold JD, Smith J. “Serpiginous Skin Lesions in a Patient with Pearson Syndrome.” Submitted.
77. Patel A, Driscoll W, Sharma A, Horton L, Smith J. “Outcomes of Breast and Scalp Angiosarcoma: A Meta-Analysis.” Submitted.
78. Chand S, Lee B, Smith J. “Metastatic Epithelioid Sarcoma: A Case Report and Review of the Literature.” Submitted.
79. Patel A, Driscoll W, Sharma A, Horton L, Smith J. “Survival Outcomes in Cutaneous Angiosarcoma: A Meta Analysis.” Dermatologic Surgery Journal. (Submitted).
80. Woll J, Smith J, Horton L. “Adverse Cardiac Events Associated with Niacinamide Use in Nonmelanoma Skin Cancer Patients.” (Submitted BJD).
81. Chapman MC, Brady BH, Smith J. “Drug Induced Subacute Cutaneous Lupus Erythematosus in a Patient on Zanidatamab and ALX 148.” Submitted.
82. Kasheri E, Smith J, Mar N. “Genomic characteristics of patients with urothelial carcinoma and cutaneous toxicity from enfortumab vedodin plus pembrolizumab.” Submitted.
83. Kasheri E, Fan X, Smith J. “Future Nonmelanoma Skin Cancer Development Following Immune Checkpoint Inhibitor 4 Therapy: A TriNetX Real-World Study.” Submitted.
84. Kasheri E, Fan X, Smith J. “Predictors of Bullous Pemphigoid Following Immune Checkpoint Inhibitor Therapy: A Retrospective Cohort Study Using TriNetX.” Submitted.
85. Woll J, Smith J, Horton L. “Niacinamide Use is Not Associated with an Increased Incidence of Major Adverse Cardiac Events in Nonmelanoma Skin Cancer Patients.” Submitted.

BOOK CHAPTERS
1. Halle B, Hutchison D, Smith J. “Geographic Tongue.” Treatment of Skin Disease, 7th Edition. 2025. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. Submitted.
2. Hutchison D, Halle B, Smith J. “Cheilitis.” Treatment of Skin Disease, 7th Edition. 2025. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. Submitted.
3. Shiu J, Chen JK, Smith J. “Angular Cheilitis.” Treatment of Skin Disease, 6th Edition. 2020. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
4. Shiu J, Chen JK, Smith J. “Geographic Tongue.” Treatment of Skin Disease, 6th Edition. 2020. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
5. Chen JK, Smith J. “Angular Cheilitis.” Treatment of Skin Disease, 5th Edition. 2017. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
6. Chen JK, Smith J. “Geographic Tongue.” Treatment of Skin Disease, 5th Edition. 2017. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
7. Chen JK, Smith J. “Angular Cheilitis.” Treatment of Skin Disease, 4th Edition. 2013. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
8. Chen JK, Smith J. “Geographic Tongue.” Treatment of Skin Disease, 4th Edition. 2013. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I.
9. Boonyaratanakornkit JB, Smith J, Ghadially R. “Metastatic Stem Cells and Melanoma.” Cancer Metastasis: From Local Proliferation to Distant Sites Through the Lymphovascular System. 2008. Leong S. Humana Press/Springer.
10. Smith J. “Panniculitis.” Principles and Practice of Dermatology, 2nd Edition. 1996. Lynch P, Sams M. Churchill Livingstone.
11. Smith J. “Panniculitis.” Principles and Practice of Dermatology, 1st Edition. 1990. Lynch P, Sams M. Churchill Livingstone.

CONFERENCE ABSTRACTS
1. Enhanced vs Standard Dermatologic Management with Amivantamab-Lazertinib in Advanced NSCLC: Phase 2 COCOON Study. 2024 World Conference on Lung Cancer. San Diego, CA. Cho BC, Girard N, Sauder MB, Feldman J, Li W, Bosorgmehr F, Mak M, Smith J, Simones J, Mahadevia P, Anderson BG, Romero T, Xia K, Wang G, Murphy S, Bauml JM, Spira AI J Thorac Oncol 19(10) S347 (2024)
2. Enhanced vs Standard Dermatologic Management with Amivantamab-Lazertinib in EGFRm Advanced NSCLC: the COCOON Global RCT,” has been submitted to the 2025 World Conference on Lung Cancer (WCLC 2025) Barcelona, Spain
3. Driscoll W, Zachary C, Patel A, Golbari N A Comparative Analysis of AI Models in Dermatology Am Academy of Dermatology
4. Patel A, Driscoll W, Sharma A, Horton L, Smith J. Outcomes of Breast Angiosarcoma: A Meta-Analysis. Women’s Dermatology Symposium, Scottsdale, AZ, 2025.
5. Patel A, Fan X, Smith J. Nail Toxicity and Management Across Fibroblast Growth Receptor Inhibitors. DIGA Symposium, 2025.
6. Genomic characteristics of patients with urothelial carcinoma and cutaneous toxicity from enfortumab vedodin (EV) plus pembrolizumab (P). American Society of Clinical Oncology, Genitourinary Cancer Symposium, San Francisco, CA, February 2026.

WEB-BASED ARTICLES/ACTIVITY
1. Society of ‘67 Open Access Award, Educational Case: Mycosis Fungoides, $1365, Association of Academic Pathology.
2. Patient Case Presentation: A 59-Year-Old Man with EGFR-Mutant NSCLC. December 2023.
3. Common Adverse Events Seen with EGFR TKIs in EGFR-Mutant NSCLC. December 2023.
4. Approaches to Managing Patients with EGFR- Mutant NSCLC and EGFR TKI Resistance. December 2023.
5. Patient Case Presentation: A 69-Year-Old Man with NSCLC with EGFR Exon 20 Insertion Mutations. December 2023.
6. Management Strategies for Adverse Events Seen with Amivantamab in NSCLC with EGFR Exon 20 Insertion Mutations. December 2023.
7. The Future of Treatment for NSCLC with EGFR Exon 20 Insertion Mutations. December 2023.
8. Unmet Needs and Future Perspectives in NSCLC Treatment. December 2023.
9. JDCR Case Challenge: “Hyperpigmented plaques and nodules in a young man.” February 2022.
10. “Almost Every Doctor Recommends Sunscreen, So Why Don’t We Know More About it’s Safety?” TIME Magazine. September 2021.
11. “Protein-Energy Malnutition.” DermNet NZ. July 2021.
12. “Spot the Tox” Case. OncoDermatology Connection. July 2020.
13. Valdebran M, Smith J. “Noncandidal Fungal Infections of the mouth." Emedicine. 2018.
14. “Exactly What to Do This Summer to Have Gorgeous Skin Forever.” Huffington Post. June 2017.
15. “According to Dermatologists, These Are The Best Mineral Sunscreens.” Huffington Post. June 2017.
16. “What’s the Deal with Natural Sunscreens?” Huffington Post. June 2016.
Professional Societies
American Dermatologic Association, 2023-Present
Pacific Dermatologic Association, 2012-Present
American Society of Contact Dermatitis, 2012-Present
California Society of Dermatology, 2008-2012
Orange County Dermatology Society, 2006-Present
National Association of VA Dermatologists, 1988-2000
Minnesota Dermatology Society, 1988-1998
Dermatology Foundation, 1986-Present
Society of Investigative Dermatology, 1986-1997
Dermatologic Photographic Society, 1984-1997
American Academy of Dermatology, 1981-Present
American Medical Association, 1982-1984
American Academy of Family Physicians, 1981-1982
American Medical Student Association, 1978-1982
Other Experience
Instructor
Division of Dermatology, Washington University, School of Medicine 1988—1988
Assistant Professor
Director of Melanoma Program, Department of Dermatology, University of Minnesota 1988—1997
Chief of Dermatology
Minneapolis VA Medical Center 1987—1997
Staff Physician
San Francisco VA Medical Center 1997—1999
Health Sciences Assistant Clinical Professor, Director
Low Risk Melanoma & Pigmented Lesion Clinic, Department of Dermatology, UC San Francisco 1997—1999
Health Sciences Associate Clinical Professor, Director
Low Risk Melanoma & Pigmented Lesion Clinic, Department of Dermatology, UC San Francisco 1999—2005
Health Sciences Clinical Professor, Director Low Risk Melanoma Pigmented Lesion Clinic
Department of Dermatology, UC San Francisco 2005—2006
Vice President
Pacific Dermatologic Association 2018—2019
President
Pacific Dermatologic Association 2015—2016
President
Orange County Dermatologic Society 2010—2011
Director
Pigmented Lesion Clinic, UC San Francisco 1997—2006
President
National Association of Veterans Administration Dermatologists 1997—1998
Director, Multidisciplinary Melanoma Program
University of Minnesota Hospitals and Clinics 1990—1997
Graduate Programs
Dermatology
Last updated
06/30/2026